Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheung, A. K.
Right arrow Articles by Leypoldt, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, A. K.
Right arrow Articles by Leypoldt, J. K.

Journal of the American Society of Nephrology, Vol 5, 110-115, Copyright © 1994 by American Society of Nephrology

REGULAR ARTICLES

Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis

AK Cheung, B Faezi-Jenkin and JK Leypoldt
Veterans Affairs Medical Center, Salt Lake City, UT 84148.

Coagulation proteins are known to affect the complement system and neutrophils. To assess the influence of thrombosis on complement and neutrophils during hemodialysis, whole human blood obtained from normal donors and anticoagulated with either 0.8 or 2.0 U/mL of heparin was recirculated for 4 h through cellulose acetate hollow fibers in vitro. Plasma fibrinopeptide A (FPA) levels were measured to assess thrombosis, whereas the activation of the complement system was evaluated at various stages by determining plasma C3a(desArg), C5a(desArg), and SC5b-9 concentrations. The activation of circulating neutrophils was assessed by quantitation of the extracellular release of the intragranular proteins elastase and lactoferrin. Thrombosis was observed when 0.8 U/mL of heparin was used, as indicated by a 36-fold increase in (FPA) levels at 240 min of recirculation and occasional grossly visible blood clots. In contrast, no increase in FPA or clot formation was observed with 2.0 U/mL of heparin. The higher dose of heparin was also associated with a lesser increase in plasma C3a(desArg) and C5a(desArg) concentrations, an observation that is compatible with either an inhibitory effect of heparin or a stimulatory effect of coagulation on the complement system. Plasma elastase or lactoferrin concentrations increased during hemodialysis but were not dependent on heparin dosage at any time. It was concluded that anticoagulation with higher heparin concentration inhibits complement activation in the hemodialysis circuit, but it does not affect neutrophil degranulation.


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
W. H. Horl
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Schmaldienst and W. H. Horl
Degranulation of polymorphonuclear leukocytes by dialysis membranes--the mystery clears up?
Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1909 - 1910.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Leitienne, D. Fouque, D. Rigal, P. Adeleine, M.-C. Trzeciak, and M. Laville
Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1631 - 1637.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673